Lv777
4824 积分 2024-09-26 加入
Sa2086 POST MARKETING NEUROPSYCHIATRIC SAFETY SIGNALS ASSOCIATED WITH RESMETIROM: AN FDA FAERS DATABASE ANALYSIS (2024-2025)
15天前
已关闭
Safety evaluation of tarlatamab: A pharmacovigilance study based on the FAERS database
15天前
已完结
Real-world safety of nemolizumab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS)
16天前
已完结
A Real‑World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
17天前
已完结
Postoperative delirium or side effects of voriconazole: pharmacist’s viewpoint
20天前
已完结
Navigating therapeutic challenges: Voriconazole pharmacokinetics and CYP2C19 genetic polymorphism—A case report and literature review
20天前
已完结
Attention to the interactions between vincristine and triazole antifungals: perspectives from real-world retrospective analysis and pharmacovigilance assessment
20天前
已完结
Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases
1个月前
已完结
Concomitant use of sodium-glucose co-transporter 2 inhibitors and metformin and the risk of osteomyelitis reporting: a disproportionality analysis based on FAERS database
1个月前
已完结
Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System
1个月前
已完结